The Role of Gene Therapy and RNA-Based Therapeutic Strategies in Diabetes
International Journal of Molecular Sciences · 22.10.2025 · 26 (21) · 10264
DOI: 10.3390/ijms262110264 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.10.2025. Verfasst von Mustafa Tariq Khan und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Royal College of Surgeons In Ireland-Medical University of Bahrain, Busaiteen P.O. Box 15503, Bahrain. Hauptthemen laut MEDLINE: Genetic Therapy, Diabetes Mellitus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Gene therapy and RNA (ribonucleic acid)-based therapeutic strategies have emerged as promising alternatives to conventional diabetes treatments, significantly expanding the therapeutic landscape using viral and non-viral vectors, and RNA modalities such as mRNA (messenger ribonucleic acid), siRNA (small interfering ribonucleic acid) and miRNA (micro ribonucleic acid). Recent advancements in these fields have led to notable preclinical successes and ongoing clinical trials, yet they are accompanied by debates over safety, efficacy and ethical considerations that underscore the complexity of clinical translation. This review offers a comprehensive analysis of the underlying mechanisms by which these treatments target diabetes, critically evaluating the fundamental concepts and mechanistic insights that form their basis, while highlighting current research gaps, such as the challenges in long-term stability and efficient delivery of RNA-based therapies, and potential adverse effects associated with gene therapy techniques. By synthesizing diverse perspectives and controversies, the review outlines future directions and interdisciplinary approaches aimed at overcoming existing hurdles, ultimately setting the stage for innovative, personalized diabetes management and addressing the broader clinical and regulatory implications of these emerging therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Royal College of Surgeons In Ireland-Medical University of Bahrain, Busaiteen P.O. Box 15503, Bahrain.
- Research Department, Royal College of Surgeons In Ireland-Medical University of Bahrain, Busaiteen P.O. Box 15503, Bahrain.
ORCID-Profile: Zainab Alhalwachi, Alexandra E Butler
Zitieren
APA
Khan, M. T., Al-Dhaleai, R. E., Alayadhi, S. M., Alhalwachi, Z., & Butler, A. E. (2025). The Role of Gene Therapy and RNA-Based Therapeutic Strategies in Diabetes. International Journal of Molecular Sciences, 26(21), 10264. https://doi.org/10.3390/ijms262110264
Vancouver
Khan MT, Al-Dhaleai RE, Alayadhi SM, Alhalwachi Z, Butler AE. The Role of Gene Therapy and RNA-Based Therapeutic Strategies in Diabetes. International Journal of Molecular Sciences. 2025;26(21):10264. doi:10.3390/ijms262110264
BibTeX
@article{Khan2025,
author = {Khan, Mustafa Tariq and Al-Dhaleai, Reem Emad and Alayadhi, Sarah M and Alhalwachi, Zainab and Butler, Alexandra E},
title = {The Role of Gene Therapy and RNA-Based Therapeutic Strategies in Diabetes},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {21},
pages = {10264},
doi = {10.3390/ijms262110264}
}
EUVIMED